Research in Alzheimer's Disease To be Revolutionized With a New Mouse Model

A tremendous social and economic burden on modern society could be imposed by Alzheimer's disease, the primary cause of dementia in the elderly. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government's annual revenues.

Unfortunately, it has proven very difficult to develop drugs capable of ameliorating the disease. After a tremendous burst of progress in the 1990s, the pace of discoveries has slowed. Dr. Saido believes that part of the difficulty is the inadequacy of current mouse models to replicate the real conditions of Alzheimer's disease and allow an understanding of the underlying mechanisms that lead to neurodegeneration. In fact, much of the research in Alzheimer's disease over the past decade may be flawed, as it was based on unrealistic models.

The problem with older mouse models is that they overexpress a protein called amyloid precursor protein, or APP, which gives rise to the amyloid-beta (Abeta) peptides that accumulate in the brain, eventually leading to the neurodegeneration that characterizes Alzheimer's disease. However, in mice the overexpression of APP gives rise to effects which are not seen in human Alzheimer's disease.

For example, the APP mutant mice often die of unknown causes at a young age, and the group believes this may be related to the generation of toxic fragments of APP, such as CTF-beta. In addition, some of the fragments of APP could be neuroprotective, making it difficult to judge whether drugs are being effective due to their effect on Abeta peptides, which are known to be involved in human AD, or whether it is due to other effects that would not be seen in human disease. In addition, the gene for expressing APP is inserted in different places in the genome, and may knock out other genes, creating artifacts that are not seen in humans.

Source: Eurekalert

Clue to Caffeine Benefit on Alzheimer's Found in Lab

Evidence has been found in the lab by French and German researchers on Wednesday, to back theories that drinking caffeine has a preventive effect on Alzheimer's disease.

Redesigning Systems of Care for Alzheimer's Disease Patients

In the United States, the number of older adults with dementia is forecast to more than double over the next 40 years.

Coffee Consumption Wards Off Alzheimer's Disease

Caffeine has a positive effect on tau deposits in Alzheimer's disease, say researchers.

Alzheimers Disease

Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

Diet and Alzheimer´s Disease

Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn''t a diet change worth it?

Genetics of Alzheimer´s disease

There are numerous genes that have been discovered that are associated with Alzheimer’s disease and indicate increased risk, aiding genetic counseling and better care.